Hero B - Search Results

1

Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.

Ertle F, Behnisch W, Al Mulla NA, Bessisso M, Rating D, Mechtersheimer G, Hero B, Kulozik AE. Ertle F, et al. Among authors: hero b. Pediatr Blood Cancer. 2008 Mar;50(3):683-7. doi: 10.1002/pbc.21107. Pediatr Blood Cancer. 2008. PMID: 17226843 Clinical Trial.

2

Testicular and paratesticular involvement by metastatic neuroblastoma.

Simon T, Hero B, Berthold F. Simon T, et al. Among authors: hero b. Cancer. 2000 Jun 1;88(11):2636-41. doi: 10.1002/1097-0142(20000601)88:11<2636::aid-cncr28>3.0.co;2-k. Cancer. 2000. PMID: 10861443 Review.

3

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.

Berthold F, Hero B, Kremens B, Handgretinger R, Henze G, Schilling FH, Schrappe M, Simon T, Spix C. Berthold F, et al. Among authors: hero b. Cancer Lett. 2003 Jul 18;197(1-2):11-7. doi: 10.1016/s0304-3835(03)00076-4. Cancer Lett. 2003. PMID: 12880954

4

Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases.

Schumacher-Kuckelkorn R, Hero B, Ernestus K, Berthold F. Schumacher-Kuckelkorn R, et al. Among authors: hero b. Pediatr Blood Cancer. 2005 Aug;45(2):195-201. doi: 10.1002/pbc.20301. Pediatr Blood Cancer. 2005. PMID: 15800908

5

Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell WG, Pike M, Pistoia V. Matthay KK, et al. Among authors: hero b. Cancer Lett. 2005 Oct 18;228(1-2):275-82. doi: 10.1016/j.canlet.2005.01.051. Cancer Lett. 2005. PMID: 15922508 Review.

6

Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.

Blaes F, Fühlhuber V, Korfei M, Tschernatsch M, Behnisch W, Rostasy K, Hero B, Kaps M, Preissner KT. Blaes F, et al. Among authors: hero b. Ann Neurol. 2005 Aug;58(2):313-7. doi: 10.1002/ana.20539. Ann Neurol. 2005. PMID: 15988749

7

Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q.

Simon T, Spitz R, Hero B, Berthold F, Faldum A. Simon T, et al. Among authors: hero b. Cancer Lett. 2006 Jun 18;237(2):215-22. doi: 10.1016/j.canlet.2005.06.001. Epub 2005 Jul 12. Cancer Lett. 2006. PMID: 16019135

8

High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.

Rostásy K, Wilken B, Baumann M, Müller-Deile K, Bieber I, Gärtner J, Möller P, Angelini P, Hero B. Rostásy K, et al. Among authors: hero b. Neuropediatrics. 2006 Oct;37(5):291-5. doi: 10.1055/s-2006-955931. Neuropediatrics. 2006. PMID: 17236108 Clinical Trial.

9

Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial.

Simon T, Längler A, Berthold F, Klingebiel T, Hero B. Simon T, et al. Among authors: hero b. J Pediatr Hematol Oncol. 2007 Feb;29(2):101-6. doi: 10.1097/MPH.0b013e3180320b48. J Pediatr Hematol Oncol. 2007. PMID: 17279006 Clinical Trial.

10

Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trial.

Simon T, Längler A, Harnischmacher U, Frühwald MC, Jorch N, Claviez A, Berthold F, Hero B. Simon T, et al. Among authors: hero b. J Cancer Res Clin Oncol. 2007 Sep;133(9):653-61. doi: 10.1007/s00432-007-0216-y. Epub 2007 May 4. J Cancer Res Clin Oncol. 2007. PMID: 17479288 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters